bpc 157 regulatory status fda Exciting news for peptides coming out of today's committee hearing! The Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- to the 503A Bulks List for use in compounding for Regulatory Alert: The Legal Status

Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA panel votes to place popular peptide BPC 157 on compounding list Reuters 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank

SKU: 55860221813 · From clintoncounty708.com